000 | 01112 a2200301 4500 | ||
---|---|---|---|
005 | 20250515003529.0 | ||
264 | 0 | _c20060126 | |
008 | 200601s 0 0 eng d | ||
022 | _a0312-5963 | ||
024 | 7 |
_a10.2165/00003088-200544110-00003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Jonge, Milly E | |
245 | 0 | 0 |
_aClinical pharmacokinetics of cyclophosphamide. _h[electronic resource] |
260 |
_bClinical pharmacokinetics _c2005 |
||
300 |
_a1135-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xmetabolism |
650 | 0 | 4 |
_aCyclophosphamide _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xmetabolism |
700 | 1 | _aHuitema, Alwin D R | |
700 | 1 | _aRodenhuis, Sjoerd | |
700 | 1 | _aBeijnen, Jos H | |
773 | 0 |
_tClinical pharmacokinetics _gvol. 44 _gno. 11 _gp. 1135-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003088-200544110-00003 _zAvailable from publisher's website |
999 |
_c15860175 _d15860175 |